A detailed history of Vanguard Group Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,287,084 shares of RXST stock, worth $102 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,287,084
Previous 2,007,938 13.9%
Holding current value
$102 Million
Previous $121 Million 6.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.78 - $57.04 $11.4 Million - $15.9 Million
279,146 Added 13.9%
2,287,084 $113 Million
Q2 2024

Aug 13, 2024

BUY
$50.42 - $64.29 $24.4 Million - $31.1 Million
483,428 Added 31.71%
2,007,938 $121 Million
Q1 2024

May 10, 2024

BUY
$35.51 - $57.92 $1.44 Million - $2.35 Million
40,500 Added 2.73%
1,524,510 $78.6 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $1.05 Million - $2.05 Million
50,057 Added 3.49%
1,484,010 $59.8 Million
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $6.9 Million - $8.51 Million
255,150 Added 21.64%
1,433,953 $40 Million
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $2.61 Million - $4.6 Million
159,310 Added 15.63%
1,178,803 $33.9 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $2.81 Million - $3.72 Million
223,228 Added 28.03%
1,019,493 $17 Million
Q4 2022

Feb 10, 2023

SELL
$9.93 - $14.2 $64,386 - $92,072
-6,484 Reduced 0.81%
796,265 $10.1 Million
Q3 2022

Nov 14, 2022

BUY
$11.19 - $15.85 $1.46 Million - $2.07 Million
130,694 Added 19.45%
802,749 $9.63 Million
Q2 2022

Aug 12, 2022

BUY
$10.61 - $16.66 $352,697 - $553,811
33,242 Added 5.2%
672,055 $9.46 Million
Q1 2022

May 13, 2022

BUY
$8.97 - $14.03 $2.7 Million - $4.22 Million
301,055 Added 89.13%
638,813 $7.91 Million
Q4 2021

Feb 14, 2022

SELL
$9.52 - $13.81 $664,448 - $963,868
-69,795 Reduced 17.13%
337,758 $3.8 Million
Q3 2021

Nov 12, 2021

BUY
$11.85 - $17.32 $4.83 Million - $7.06 Million
407,553 New
407,553 $5.16 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.